|
Epilepsy is a debilitating disorder that affects millions of individuals in the US and throughout the world. We are developing novel treatments for epilepsy that are currently undergoing preclinical and clinical investigation.
Learn More >
|
|
|
|
Pain affects more individuals in the US than diabetes, heart disease and cancer combined. Icagen is pursuing next-generation ion channel modulators to manage various pain states more effectively and with fewer side effects compared to available therapies. We are currently collaborating with Pfizer on compounds targeting three different sodium channel subtypes.
Learn More >
|
|
|
